These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 34853626)
1. Nucleation kinetics of calcium oxalate monohydrate as a function of pH, magnesium, and osteopontin concentration quantified with droplet microfluidics. Ibis F; Yu TW; Penha FM; Ganguly D; Nuhu MA; van der Heijden AEDM; Kramer HJM; Eral HB Biomicrofluidics; 2021 Dec; 15(6):064103. PubMed ID: 34853626 [TBL] [Abstract][Full Text] [Related]
2. The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones. Langdon A; Grohe B Colloids Surf B Biointerfaces; 2016 Oct; 146():296-306. PubMed ID: 27362921 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization. Wang L; Guan X; Tang R; Hoyer JR; Wierzbicki A; De Yoreo JJ; Nancollas GH J Phys Chem B; 2008 Jul; 112(30):9151-7. PubMed ID: 18611047 [TBL] [Abstract][Full Text] [Related]
4. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein. Schwille PO; Schmiedl A; Manoharan M Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561 [TBL] [Abstract][Full Text] [Related]
5. Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy. Langdon A; Wignall GR; Rogers K; Sørensen ES; Denstedt J; Grohe B; Goldberg HA; Hunter GK Calcif Tissue Int; 2009 Mar; 84(3):240-8. PubMed ID: 19189038 [TBL] [Abstract][Full Text] [Related]
11. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation. Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440 [TBL] [Abstract][Full Text] [Related]
12. Idiopathic calcium nephrolithiasis with pure calcium oxalate composition: clinical correlates of the calcium oxalate dihydrate/monohydrate (COD/COM) stone ratio. Guerra A; Ticinesi A; Allegri F; Pinelli S; Aloe R; Meschi T Urolithiasis; 2020 Jun; 48(3):271-279. PubMed ID: 31506762 [TBL] [Abstract][Full Text] [Related]
13. Aggregation of Calcium Phosphate and Oxalate Phases in the Formation of Renal Stones. Xie B; Halter TJ; Borah BM; Nancollas GH Cryst Growth Des; 2015 Jan; 15(1):204-211. PubMed ID: 25598742 [TBL] [Abstract][Full Text] [Related]
14. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Bushinsky DA; Parker WR; Asplin JR Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032 [TBL] [Abstract][Full Text] [Related]
15. Attachment of calcium oxalate monohydrate crystals on patterned surfaces of proteins and lipid bilayers. An Z; Lee S; Oppenheimer H; Wesson JA; Ward MD J Am Chem Soc; 2010 Sep; 132(38):13188-90. PubMed ID: 20812679 [TBL] [Abstract][Full Text] [Related]
16. Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals. Asplin J; DeGanello S; Nakagawa YN; Coe FL Am J Physiol; 1991 Nov; 261(5 Pt 2):F824-30. PubMed ID: 1951713 [TBL] [Abstract][Full Text] [Related]
17. The effect of intracrystalline and surface-bound osteopontin on the degradation and dissolution of calcium oxalate dihydrate crystals in MDCKII cells. Thurgood LA; Sørensen ES; Ryall RL Urol Res; 2012 Feb; 40(1):1-15. PubMed ID: 21932131 [TBL] [Abstract][Full Text] [Related]